Navigation Links
New self-management program offers significant benefits for arthritis patients with chronic pain
Date:6/12/2008

rogramme, which was offered free of charge to patients, equipped them with the practical skills and techniques to help combat their pain, whilst also giving them an empowering sense of control and confidence in their own disease management. Achieving sustained results 6 and 12 months after a short course offers great promise for both arthritis patients and healthcare providers alike. Arthritis Care has now begun a UK-wide rollout of the programme, and a similar roll-out is beginning in Australia. We are delighted to share our results at the international forum of EULAR, as centres across other countries might be similarly inspired by our results"


'/>"/>

Contact: Rory Berrie / Camilla Dormer
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Self-Management Program Helps Diabetics
2. COSE Introduces Health Incentives, Wellness Programs for Medium-Size Businesses
3. A self-help program delivered online can improve insomnia in adults
4. 30th Street Senior Center and Posit Science Put Their Heads Together On New Program
5. AUDIO from Medialink and Pfizer: Free Programs for Uninsured Men and Women Who Need Help Paying for Medicine
6. Best-in-Class Engagement Programs: Employees See Link Between Quality & Performance
7. Miami Institute Launches New Weight Loss Program
8. Los Angeles Jewish Home Increases Resident Capacity and Adds New Programs to Address Community Needs
9. WellPoint Launches and Expands Maternity Depression Program
10. Statewide Pay-For-Performance Program in Store for New York Physicians
11. BlueChoice HealthPlan to Launch Back Care Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...uthor James A. Feinstein, MD, has just released hi...s from Patients on Becoming a Doctor, that traces ...hool--the grueling clinical year. , ...009 -- Most people will, at some point or another,... gown or staring at someone else dressed in a tiny...
(Date:12/2/2009)...e-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: G...y Health Care Conference today at 2:30 p.m. Easter...t live and may be accessed through a link on the i...n-probe.com . The webcast will be available for 30... ,, Gen-Probe Incorporated is a global leader ...
(Date:12/2/2009)...wire/ -- LeapFrog Investments has announced a ZAR ...fe, the innovative South African insurer serving p... brings together LeapFrog, the leading microinsura...most innovative insurance businesses. The announce...fe has developed a distinctive and profitable busi...
(Date:12/2/2009)...cal trial presented today at the annual meeting of...provide the first strong evidence of the benefit o... breasts who are at elevated risk for breast cance...ghly sensitive in depicting early breast cancer. ,... in addition to mammography significantly improves...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2
...spital which is to be built on the site of Birming...gnal. The plans for this new ?600m super hospital .../. It is funded by a private finance initiative. ...ble. The Treasury has also approved the schem...
...ying a drive for better hygiene at rural levels, t... its threats against panchayat leaders who fail to...s. Last year the state assembly had amended th...lush in their homes within a year of being elected...
...ts have discovered that watching television for an...167 calories thereby adding over than six kilogram...ve discovered that watching television for an hour...n the first to put an exact figure has been put on...
...ead of the NHS, Sir Ian Carruthers, has proposed c...million NHS deficit//. He proposes to unveil h...ony Blair. Sir Ian believes the ?10.3 billion spen... they could benefit have arisen. NHS had been ...
...s syndrome, a common running ailment, can be treat...g to Dr. Ronald Adler, chief, Division of Ultrasou...be used to accurately diagnose the ailment and rel...ed by the back of the shoe consistently rubbing ag...
...who was convicted of murdering Lin Russell and her...he publication of a report that probes the failure...ling spree. // The independent report by Robert..., Josie and her father, Shaun wants the report to ...
Other Medicine News:Health News:Madhya Pradesh To Concentrate On Better Rural Hygiene 2Health News:Watching TV Blamed for Weight Gain 2Health News:Proper Diagnosis Could Augment Speedy Recovery Of Haglund’s Syndrom 2
(Date:12/1/2009)...., Dec. 1 CeloNova BioSciences, In... medical devices and of specialty implants, today ..., founder and medical director of Baptist Cardiac ...iscuss the CATANIA(TM) Stent System with NanoThin ...lar Interventions Conference to be held at the Hot...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
(Date:12/1/2009)...., Dec. 1 SCOLR Pharma, ... 20, 2009 it licensed to Chrono Nutraceuticals LLC...l four extended release dietary supplements using ...rm. In addition, SCOLR granted Chrono rights to m...ited States on a nonexclusive basis. Chrono paid ...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 1Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 2Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 3The tourist trap 9540 1
...ial New Front-Line Treatment ...Genzyme Corp.,(Nasdaq: GENZ ) reported preliminar...2 study examining the safety and effectiveness of ...ously untreated, older adult,patients with acute m...fit,from conventional "7+3" anthracycline plus cyt...
...CALS, INC. (Nasdaq: VION ) today announced that i... lead anticancer agent Cloretazine(R),(VNP40101M) ...yelogenous,leukemia (AML) had been presented at th...linical Oncology (ASCO(R)) in Chicago, Illinois., ...atients. The median,age of these patients was 73 y...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4
Fast-Cath™ Guiding Introducers
Lumenis 1000 Integrated Slit Lamp
Novus 30001
Selecta Trio Photocoagulator and SLT Combination Laser
Medicine Products: